SCHEMBL30178764

SCHEMBL30178764

BrCCCCOc1ccccc1I

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
PTK2B Q14289 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
KCNA3 P22001 2/20 0.37
MAPT P10636 3/20 0.36
JAK2 O60674 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
F2 P00734 1/20 0.36
PLAU P00749 1/20 0.36
ST14 Q9Y5Y6 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24838711 1.00 L3MBTL1 (0.38) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL28348682 0.98 NPC1 (0.41) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL28348108 0.98 NPC1 (0.41) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL28348109 0.98 NPC1 (0.41) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL28348359 0.98 NPC1 (0.41) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL23869372 0.94 KDM4E (0.39) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL22005040 0.89 KDM4E (0.44) L3MBTL1TDP1NPC1POLBPTK2B
SCHEMBL23630245 0.88 KDM4E (0.40) L3MBTL1TDP1NPC1PTK2BALDH1A1
SCHEMBL30291428 0.88 KDM4E (0.40) L3MBTL1TDP1NPC1PTK2BALDH1A1
SCHEMBL22005008 0.87 NPC1 (0.47) L3MBTL1TDP1NPC1POLBPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239645-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-12-14 WO disclosed
WO-2023278402-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-01-05 WO disclosed